Skip to main content
. 2020 Feb 20;23(2):65–76. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2020.02.01

1.

1

晚期NSCLC的治疗路径

Treatment pathways for advanced NSCLC. Non-Sq.: non-squamous; Sq.: squamous; EGFR: epidermal growth factor receptor; ALK: anaplastic lymphoma kinase; MT: mutation; TKI: tyrosine kinase inhibitors; Chemo: chemotherapy; I.O. mono: immuno monotherapy